Market Scenario 

Global Enteral Nutrition Market was valued at US$ 8.64 billion in 2023 and is projected to surpass the market valuation of US$ 17.20 billion by 2032 at a CAGR of 7.95% during the forecast period 2024–2032.

The burden of chronic diseases such as diabetes, heart disease, cancer, and chronic pulmonary diseases is growing globally. According to the World Health Organization, chronic diseases are estimated to account for 73% of all deaths worldwide by 2023. Many patients suffering from these conditions become malnourished due to decreased appetite or difficulty consuming food, necessitating the use of enteral nutrition.

Moreover, the aging population is increasing rapidly, especially in developed countries. In 2020, the United Nations estimated that the number of individuals aged 65 years or older would double from 727 million to over 1.5 billion by 2050. This population is more prone to chronic diseases and often requires enteral nutrition as part of their treatment or to maintain their nutrition status.

Additionally, the increasing rate of hospital admissions globally has been directly influencing the demand for enteral nutrition. As per a recent study, out of the total hospital admissions, approximately 25% of patients require some form of nutritional support due to malnourishment or their inability to eat, with a significant portion of these patients requiring tube feeding.

Considering the current market dynamics, the enteral nutrition market is showing a significant upward trend. There is a growing awareness of the benefits of enteral nutrition, not only in the patient population but also among healthcare providers. Moreover, advancements in the technology and formulations used in enteral nutrition products, and the development of home-based enteral nutrition programs, are further driving the growth of this market.

To Get more Insights,  Request A Free Sample 

Market Dynamics 

Market Driver: Increasing Hospital Admissions and Need for Nutritional Support

The escalating number of hospital admissions globally is a significant driver propelling the growth of the enteral nutrition market. The surge in admissions is primarily due to the rising prevalence of various illnesses, including chronic diseases, acute conditions, and post-surgical care. Many of these patients, particularly those suffering from severe illnesses or undergoing complex surgeries, require additional nutritional support to recover.

In fact, research indicates that around 25% of all hospital patients require some form of nutritional assistance due to malnourishment or their inability to eat independently. Enteral nutrition, which ensures the provision of necessary nutrients through a tube directly into the digestive tract, is a preferred option in many cases. It helps in promoting healing, maintaining muscle mass, and improving patients' overall health status.

Moreover, enteral nutrition is increasingly being used in intensive care units. Patients in critical conditions often have higher nutritional needs, and enteral nutrition helps in fulfilling these requirements effectively. Consequently, the growing number of hospital admissions demanding nutritional support significantly drives the enteral nutrition market.

The expansion of this market is also fueled by the wider acceptance and awareness of the benefits of enteral nutrition among healthcare professionals and patients alike. Increased recognition of malnutrition as a critical factor in patient recovery has prompted clinicians to prioritize nutritional support, thereby augmenting the enteral nutrition market.

Market Challenge: Complications Associated with Tube Feeding

Although the enteral nutrition market is experiencing substantial growth, certain challenges could potentially hamper its development. One such challenge is the risk of complications associated with tube feeding. These complications can range from minor issues such as skin irritation around the feeding site to more severe problems like infection, blockage or dislodgment of the feeding tube, or aspiration, which can lead to pneumonia.

Additionally, digestive complications like constipation, diarrhea, nausea, and bloating are common among patients receiving enteral nutrition. Managing these complications can increase the overall cost of patient care and cause discomfort, potentially leading to poor compliance with the treatment plan. Moreover, these complications can also influence the healthcare provider's decision to choose alternative methods of nutrition, thereby affecting the market growth negatively.

Market Trend: Technological Advancements and Home-Based Care

One of the significant trends impacting the global enteral nutrition market is the advent of technological advancements. The development of more sophisticated, user-friendly enteral feeding devices has made the administration of enteral nutrition more comfortable and safer for patients. Furthermore, advancements in nutrition formulation, including disease-specific formulas and modular components, allow for more personalized and effective nutritional support.

Another prominent trend is the growing shift towards home-based care, driven by the rising healthcare costs and the desire for more comfortable and familiar surroundings for recovery. With this shift, there is a growing demand for home-based enteral nutrition therapies, significantly expanding the patient base. Home enteral nutrition (HEN) not only reduces healthcare costs but also improves patients' quality of life, making it an appealing option for many. Consequently, the continued technological advancements and growing inclination towards home-based care are set to shape the enteral nutrition market's future.

Segmental Analysis 

By Type

The global enteral nutrition market is segmented by type, with the standard protein diet currently dominating the market. As of the latest data, the standard protein diet segment holds a substantial 51.4% share of the market.

Standard protein diets are typically used to meet the daily nutritional needs of patients who have difficulty eating or are unable to eat at all. This type of diet provides balanced nutrition, including proteins, carbohydrates, fats, vitamins, and minerals. Given that proteins are essential for healing, growth, and maintaining a healthy immune system, the standard protein diet plays a critical role in patient recovery and overall well-being.

With the rising prevalence of chronic diseases, an aging population, and increasing hospital admissions, the demand for standard protein diets is projected to grow even further. Additionally, advancements in nutritional science and technology have led to the development of more effective and easy-to-use protein diet products. These advancements, coupled with growing awareness about the importance of nutritional support in patient recovery, are expected to drive the standard protein diet segment at a healthy compound annual growth rate (CAGR) of 8.4% in the coming years.

By Application

In terms of application, the global enteral nutrition market is dominated by hospital sales, which account for the largest share of 63% in the market. This dominance is primarily due to the high number of patients admitted to hospitals who require nutritional support.

Hospitals are often the first point of contact for patients with severe or chronic illnesses. Many of these patients experience nutritional deficiencies or have difficulty eating, thereby necessitating the use of enteral nutrition. Moreover, hospitals have the necessary resources, such as trained healthcare professionals and advanced equipment, to administer enteral nutrition safely and effectively.

With the continuing rise in the global burden of chronic diseases, the number of patients requiring hospitalization and, subsequently, nutritional support is expected to increase. Additionally, the ongoing efforts to improve hospital infrastructure and services, especially in emerging economies, will likely contribute to the growing demand for enteral nutrition products in hospitals.

Consequently, the hospital sales segment of the enteral nutrition market is projected to continue its growth trajectory, with an estimated CAGR of 7.96% in the upcoming years. The growth in this segment signifies the crucial role of hospitals in providing enteral nutritional support to patients and improving their health outcomes.

 To Understand More About this Research:  Request A Free Sample 

Regional Analysis 

As of the current data, North America represents the largest market for enteral nutrition. The dominance of this region can be attributed to a multitude of factors, including a high prevalence of chronic diseases, significant healthcare spending, extensive insurance coverage, and a considerable number of hospitalizations.

The chronic disease burden in the United States is significant and continues to grow. According to the Centers for Disease Control and Prevention (CDC), six in ten adults in the U.S. have a chronic disease, and four in ten adults have two or more. Conditions such as heart disease, cancer, and diabetes not only lead to a reduced quality of life but also necessitate the need for nutritional support in many cases, driving demand for enteral nutrition.

North America, especially the United States, has one of the highest healthcare spending globally. In 2021, U.S. healthcare spending was estimated to be around $4.1 trillion, which constitutes about 18% of the country's Gross Domestic Product (GDP). Such high expenditure indicates a robust healthcare infrastructure and the capability to afford nutritional support systems like enteral nutrition for patients in need. Furthermore, insurance penetration in this region is quite high, which also influences the enteral nutrition market. A vast majority of U.S. citizens have some form of health insurance coverage, enabling them to afford medical treatments and nutritional support. In 2020, around 92% of the U.S. population had health insurance, according to the U.S. Census Bureau.

In terms of hospitalization, both the U.S. and Canada see a high number of hospital admissions annually. As per a report from the Canadian Institute for Health Information, there were about 1 million hospital admissions in Canada in 2020. The American Hospital Association estimates approximately 36.5 million hospital admissions in the United States during the same period in the enteral nutrition market. A significant proportion of these patients require nutritional support during their hospital stay, adding to the demand for enteral nutrition.

Apart from this, a substantial number of people in the region require tube feeding, either due to conditions that prevent normal feeding or due to the requirement of enhanced nutritional support. While exact figures may vary, studies suggest that up to 345,000 people in the United States live with long-term tube feeding at home.

Recent Developments 

• In 2021, Abbott (US) launched plant-based proteins and organic food ingredient enteral formulas for tube feeding. These new products are designed to meet the needs of patients with specific dietary restrictions.
• In 2022, Danone (France) launched a new line of modular enteral nutrition products that are designed to be customized to meet the individual needs of patients. These new products are part of Danone's ongoing commitment to innovation in the enteral nutrition market.

Top Players in the Global Enteral Nutrition Market 

• Global Health Products, Inc.
• Mead Johnson Nutrition Company
• Meiji Holdings Co., Ltd.
• Nestlà Health Science
• Danone SA
• B. Braun Melsungen AG
• Victus, In.
• Abbott Laboratories
• Hormel Foods Corporation
• Fresenius Kabi AG
• Abbott Laboratories
• Other Prominent Players

Market Segmentation Overview:

By Type

• Standard Protein Diet
• High Protein Supplement
• Protein for Diabetes Care Patient
• Others

By Application

• Hospital Sales
• Retail
• Online

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
• South America
  • Argentina
  • Brazil
  • Rest of South America